<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<title>Kratom Case Reports by Body System | Kratom Regulatory Review</title>

<meta name="description" content="Organized index of published kratom case reports categorized by body system. Neutral summaries and direct PDF links for legislative and regulatory review.">

<link rel="canonical" href="https://kratomregulatoryreview.org/KratomCaseReports.html">

<!-- Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-MQKC65VZVY"></script>
<script async src="https://www.googletagmanager.com/gtag/js?id=G-P31PD1SSTD"></script>
<script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config','G-MQKC65VZVY');
gtag('config','G-P31PD1SSTD');
</script>

<link rel="stylesheet" href="css/style.css">

<style>
.case-list { list-style:none; padding:0; margin:0; display:grid; gap:14px; }
.case-item { background:#fff; border:1px solid #e2e8f0; border-radius:12px; padding:16px; }
.case-title { font-weight:600; margin-bottom:6px; }
.case-summary { font-size:14px; color:#374151; margin-bottom:8px; }
.case-link { font-size:14px; text-decoration:none; color:#0c2d48; border:1px solid #0c2d48; padding:6px 10px; border-radius:8px; display:inline-block; }
.case-link:hover { background:#0c2d48; color:#fff; }
</style>

</head>

<body>

<div class="gov-banner">
ðŸ‡ºðŸ‡¸ Informational public health resource. Educational reference for legislative and regulatory review.
</div>

<header class="site-header">
  <div class="container header-inner">
    <div class="site-title">Kratom Regulatory Review</div>
  </div>
</header>

<nav class="main-nav">
  <div class="container nav-inner">
    <a href="index.html">Overview</a>
    <a href="KratomCaseReports.html">Case Reports</a>
  </div>
</nav>

<section class="hero">
  <div class="container">
    <h1>Kratom Case Reports</h1>
    <p class="hero-subtext">
      The following published case reports are organized by primary body system.
      Summaries are derived from article titles and abstracts where available.
      Case reports describe individual clinical observations and do not establish incidence or causation.
    </p>
  </div>
</section>
<!-- ================= CARDIOVASCULAR ================= -->
<section class="section" id="cardiovascular">
  <div class="container">
    <h2>Cardiovascular</h2>
    <ul class="case-list">

      <li class="case-item">
        <div class="case-title">Case report 3 â€“ Ventricular fibrillation during football training</div>
        <div class="case-summary">Adolescent case describing ventricular fibrillation temporally associated with reported kratom and caffeine use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%203%20-%20Ventricular%20fibrillation%20during%20football%20training%20as%20a%20consequence%20of%20kratom%20and%20caffeine%20use%20in%20an%20adolescent.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case study 2 â€“ Kratom Cardiotoxicity Reversible Brugada Pattern and QTc Prolongation</div>
        <div class="case-summary">Electrophysiologic case report describing conduction abnormalities and QTc prolongation associated with kratom exposure.</div>
        <a class="case-link" href="MAHA/casereports/Case%20study%202%20Kratom%20Cardiotoxicity%20Reversible%20Brugada%20Pattern%20and%20QTc%20Prolongation.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 43 â€“ Ventricular fibrillation in a 44-year-old man</div>
        <div class="case-summary">Adult case report describing ventricular arrhythmia temporally associated with reported kratom ingestion.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2043%20Report%20of%20ventricular%20fibrillation%20in%20a%2044-year-old%20man%20using%20kratom.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 48 â€“ Cardiac arrest in a young healthy male</div>
        <div class="case-summary">Case describing cardiac arrest following reported kratom ingestion.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2048%20Cardiac%20arrest%20in%20a%20young%20healthy%20male%20patient%20secondary%20to%20kratom%20ingestion.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 49 â€“ Undifferentiated shock with extreme procalcitonin elevation</div>
        <div class="case-summary">Case report describing shock physiology temporally associated with kratom use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2049%20Undifferentiated%20Shock%20and%20Extreme%20Elevation%20of%20Procalcitonin%20Related%20to%20Kratom%20Use.pdf" target="_blank">Open PDF</a>
      </li>

    </ul>
  </div>
</section>

<!-- ================= FATAL / FORENSIC TOXICOLOGY ================= -->
<section class="section alt-bg" id="fatal-toxicology">
  <div class="container">
    <h2>Fatal Toxicology and Postmortem Reports</h2>
    <ul class="case-list">

      <li class="case-item">
        <div class="case-title">Case report 9 â€“ Two Single-Drug Fatal Intoxications by Mitragynine</div>
        <div class="case-summary">Forensic case reports describing fatalities in which mitragynine was detected postmortem.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%209%20-%20Two%20Single-Drug%20Fatal%20Intoxications%20by%20Mitragynine.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case study 6 â€“ Postmortem Mitragynine Distribution in a Single Drug Fatality</div>
        <div class="case-summary">Forensic distribution analysis of mitragynine concentrations in a fatal case.</div>
        <a class="case-link" href="MAHA/casereports/Case%20study%206%20-%20Postmortem%20Mitragynine%20Distribution%20in%20a%20Single%20Drug%20Fatality%20Case.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 16 â€“ Mitragynine concentrations in two fatalities</div>
        <div class="case-summary">Toxicologic case report documenting postmortem mitragynine concentrations.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2016%20-%20Mitragynine%20concentrations%20in%20two%20fatalities.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 16 â€“ Fatal combination of mitragynine and quetiapine</div>
        <div class="case-summary">Forensic case describing fatal polypharmacy involving mitragynine.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2016%20-%20Fatal%20combination%20of%20mitragynine%20and%20quetiapine.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 58 â€“ Death from Kratom toxicity</div>
        <div class="case-summary">Forensic case report describing fatal toxicity attributed to kratom exposure.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2058%20Death%20from%20Kratom%20toxicity%20and%20the%20possible%20role%20of%20intralipid.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case study 4 â€“ Fatal overdose involving hydromorphone and kratom</div>
        <div class="case-summary">Fatal polypharmacy case including kratom among substances detected.</div>
        <a class="case-link" href="MAHA/casereports/Case%20study%204%20-%20A%20case%20of%20fatal%20overdose%20involving%20both%20hydromorphone%20and%20kratom.pdf" target="_blank">Open PDF</a>
      </li>

    </ul>
  </div>
</section>

<!-- ================= MULTI-SYSTEM TOXICITY ================= -->
<section class="section" id="multi-system">
  <div class="container">
    <h2>Multi-System Toxicity</h2>
    <ul class="case-list">

      <li class="case-item">
        <div class="case-title">Case report 35 â€“ Multiorgan Dysfunction Related to Kratom Ingestion</div>
        <div class="case-summary">Case report describing multi-organ dysfunction temporally associated with reported kratom ingestion.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2035%20Multiorgan%20Dysfunction%20Related%20to%20Kratom%20Ingestion.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 35 â€“ A Rare Case Presentation of Kratom Toxicity</div>
        <div class="case-summary">Clinical case report describing atypical toxicity in the context of kratom exposure.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2035%20A%20Rare%20Case%20Presentation%20of%20Kratom%20Toxicity.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 30 â€“ Mitragyna speciosa (Kratom) poisoning</div>
        <div class="case-summary">Poisoning case report detailing clinical findings after kratom ingestion.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2030%20Mitragyna%20speciosa%20%28Kratom%29%20poisoning.pdf" target="_blank">Open PDF</a>
      </li>

    </ul>
  </div>
</section>

  <!-- ================= HEPATIC & GASTROINTESTINAL ================= -->
<section class="section alt-bg" id="hepatic">
  <div class="container">
    <h2>Hepatic and Gastrointestinal</h2>
    <ul class="case-list">

      <li class="case-item">
        <div class="case-title">Case report 37 â€“ Kratom-Induced Liver Injury</div>
        <div class="case-summary">Case report describing liver injury temporally associated with kratom ingestion.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2037%20Kratom-Induced%20Liver%20Injury.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 38 â€“ Kratom-induced transaminitis</div>
        <div class="case-summary">Hepatic enzyme elevation reported in association with kratom exposure.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2038%20Kratom-induced%20transaminitis%20with%20subsequent%20precipitated%20opioid%20withdrawal%20following%20naltrexone.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 57 â€“ Histologic Characterization of Kratom Use-Associated Liver Injury</div>
        <div class="case-summary">Pathologic findings associated with kratom-related liver injury.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2057%20Histologic%20Characterization%20of%20Kratom%20Use-Associated%20Liver%20Injury.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 51 â€“ Kratom-Induced Cholestatic Liver Injury</div>
        <div class="case-summary">Cholestatic pattern of liver injury associated with kratom use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2051%20Kratom-Induced%20Cholestatic%20Liver%20Injury%20and%20Its%20Conservative%20Management.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 44 â€“ Severe cholestatic liver injury mimicking primary biliary cholangitis</div>
        <div class="case-summary">Severe cholestatic presentation reported following kratom ingestion.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2044%20Kratom%20induced%20severe%20cholestatic%20liver%20injury%20histologically%20mimicking%20primary%20biliary%20cholangitis.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 23 â€“ Severe jaundice with life-threatening liver failure</div>
        <div class="case-summary">Case describing acute hepatic failure temporally associated with kratom use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2023%20Severe%20jaundice%20with%20life-threatening%20liver%20failure%20after%20Kratom%20use.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case study 7 â€“ Mixed Cholestatic-Hepatocellular Liver Injury</div>
        <div class="case-summary">Mixed-pattern liver injury reported in association with kratom exposure.</div>
        <a class="case-link" href="MAHA/casereports/Case%20study%207%20-%20research-article2022%20Kratom-Associated%20Mixed%20Cholestatic-Hepatocellular%20Liver%20Injury%20in%20a%20Patient%20With%20Long%20COVID.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 28 â€“ Kratom-induced acute liver injury</div>
        <div class="case-summary">Acute liver injury temporally associated with kratom ingestion.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2028%20Kratom-induced%20acute%20liver%20injury.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 33 â€“ Kratom-Induced Hepatitis</div>
        <div class="case-summary">Case describing inflammatory hepatitis associated with kratom use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2033%20Kratom%20%28Mitragyna%20speciosa%29-Induced%20Hepatitis.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 53 â€“ Drug-Induced Liver Injury</div>
        <div class="case-summary">Drug-induced liver injury reported in context of kratom use as pain alternative.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2053%20Drug-Induced%20Liver%20Injury%20Caused%20by%20Kratom%20Use%20as%20an%20Alternative%20Pain%20Treatment%20Amid%20an%20Ongoing%20Opioid%20Epidemic.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 31 â€“ Kratom-induced common bile duct dilation</div>
        <div class="case-summary">Case report describing biliary system changes temporally associated with kratom ingestion.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2031%20Kratom-induced%20common%20bile%20duct%20dilation.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 29 â€“ Adverse Drug Interaction with Gastrointestinal and Hepatic Effects</div>
        <div class="case-summary">Adverse interaction involving kratom and amitriptyline with hepatic and GI manifestations.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2029%20Adverse%20Drug%20Interaction%20Between%20Kratom%20and%20Amitriptyline%20With%20Gastrointestinal%20and%20Mild%20Hepatic%20Effects.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 32 â€“ Hyperkalemia Induced by Kratom</div>
        <div class="case-summary">Metabolic electrolyte disturbance temporally associated with kratom use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2032%20A%20Case%20of%20Hyperkalemia%20Induced%20by%20Kratom%20%28Mitragyna%20speciosa%29.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 32 â€“ Life-Threatening Hyponatremia</div>
        <div class="case-summary">Severe electrolyte imbalance reported in association with chronic kratom use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2032%20Life-Threatening%20Hyponatremia%20Secondary%20to%20Chronic%20Kratom%20Use.pdf" target="_blank">Open PDF</a>
      </li>

    </ul>
  </div>
</section>

  <!-- ================= NEUROLOGIC ================= -->
<section class="section" id="neurologic">
  <div class="container">
    <h2>Neurologic</h2>
    <ul class="case-list">

      <li class="case-item">
        <div class="case-title">Case report 13 â€“ Kratom-induced Seizures</div>
        <div class="case-summary">Case report describing seizure activity temporally associated with kratom use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2013%20A%20Case%20of%20Kratom-induced%20Seizures.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 18 â€“ Seizure and coma following kratom exposure</div>
        <div class="case-summary">Neurologic case describing seizure and coma following reported kratom ingestion.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2018%20-%20Seizure%20and%20coma%20following%20Kratom%20%28Mitragynina%20speciosa%20Korth%29%20exposure.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 60 â€“ Posterior reversible leukoencephalopathy syndrome</div>
        <div class="case-summary">Case report describing neurologic imaging findings temporally associated with kratom ingestion.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2060%20Posterior%20reversible%20leukoencephalopathy%20syndrome%20after%20kratom%20ingestion.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 41 â€“ Transient Paralysis</div>
        <div class="case-summary">Case describing transient neurologic deficit temporally associated with kratom toxicity.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2041%20Transient%20Paralysis%20A%20Novel%20Expression%20of%20Kratom%20Toxicity%20in%20Humans.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 14 â€“ Intracerebral Hemorrhage</div>
        <div class="case-summary">Case report involving kratom adulterated with phenylethylamine and associated intracerebral hemorrhage.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2014%20Kratom%20Adulterated%20with%20Phenylethylamine%20and%20Associated%20Intracerebral%20Hemorrhage%20Linking%20Toxicologists%20and%20Public%20Health%20Officials%20to%20Identify%20Dangerous%20Adulterants.pdf" target="_blank">Open PDF</a>
      </li>

    </ul>
  </div>
</section>

<!-- ================= PSYCHIATRIC & SUBSTANCE USE ================= -->
<section class="section alt-bg" id="psychiatric">
  <div class="container">
    <h2>Psychiatric and Substance Use</h2>
    <ul class="case-list">

      <li class="case-item">
        <div class="case-title">Case report 36 â€“ Kratom-Induced Psychosis</div>
        <div class="case-summary">Case report describing psychotic symptoms temporally associated with kratom use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2036%20A%20Case%20Report%20of%20Kratom-Induced%20Psychosis.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 22 â€“ Psychiatric Decompensation and Paranoid Delusions</div>
        <div class="case-summary">Case describing psychiatric decompensation temporally associated with kratom use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2022%20Kratom-Induced%20Psychiatric%20Decompensation%20and%20Paranoid%20Delusions.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 55 â€“ Recurrent seizures from chronic kratom use</div>
        <div class="case-summary">Case describing recurrent neurologic complications in the context of chronic kratom use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2055%20Recurrent%20seizures%20from%20chronic%20kratom%20use%2C%20an%20atypical%20herbal%20opioid.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 61 â€“ Kratom Addiction and Withdrawal</div>
        <div class="case-summary">Case report documenting kratom use disorder and withdrawal manifestations.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2061%20A%20Case%20Report%20of%20Kratom%20Addiction%20and%20Withdrawal.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case study 5 â€“ Management of Kratom Use Disorder</div>
        <div class="case-summary">Clinical management case involving treatment of kratom use disorder with buprenorphine and naloxone.</div>
        <a class="case-link" href="MAHA/casereports/Case%20study%205%20-%20Successful%20Management%20of%20Kratom%20Use%20Disorder%20With%20Buprenorphine%20and%20Naloxone.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 31 â€“ Severe Kratom Addiction Contributing to Suicide Attempt</div>
        <div class="case-summary">Case report describing kratom use disorder in context of psychiatric crisis.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2031%20Case%20of%20Severe%20Kratom%20Addiction%20Contributing%20to%20a%20Suicide%20Attempt.pdf" target="_blank">Open PDF</a>
      </li>

    </ul>
  </div>
</section>

<!-- ================= ENDOCRINE ================= -->
<section class="section" id="endocrine">
  <div class="container">
    <h2>Endocrine</h2>
    <ul class="case-list">

      <li class="case-item">
        <div class="case-title">Case report 56 â€“ Raises Prolactin and Causes Secondary Hypogonadism</div>
        <div class="case-summary">Endocrine case report describing hyperprolactinemia with secondary hypogonadism associated with kratom use.</div>
        <a class="case-link" href="MAHA/casereports/%20Case%20%20report%2056%20Kratom%2C%20an%20Emerging%20Drug%20of%20Abuse%2C%20Raises%20Prolactin%20and%20Causes%20Secondary%20Hypogonadism.pdf" target="_blank">Open PDF</a>
      </li>

    </ul>
  </div>
</section>

<!-- ================= PREGNANCY & NEONATAL ================= -->
<section class="section alt-bg" id="neonatal">
  <div class="container">
    <h2>Pregnancy and Neonatal</h2>
    <ul class="case-list">

      <li class="case-item">
        <div class="case-title">Case report 59 â€“ Maternal and Neonatal Kratom Dependence</div>
        <div class="case-summary">Case report documenting maternal kratom use and neonatal withdrawal manifestations.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2059%20Novel%20case%20of%20maternal%20and%20neonatal%20kratom%20dependence%20and%20withdrawal.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 54 â€“ Neonatal abstinence syndrome secondary to kratom</div>
        <div class="case-summary">Case describing neonatal abstinence syndrome associated with maternal kratom use.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2054%20Neonatal%20abstinence%20syndrome%20secondary%20to%20%E2%80%98kratom%E2%80%99.pdf" target="_blank">Open PDF</a>
      </li>

      <li class="case-item">
        <div class="case-title">Case report 52 â€“ Neonatal abstinence syndrome</div>
        <div class="case-summary">Case describing neonatal withdrawal symptoms associated with maternal kratom exposure.</div>
        <a class="case-link" href="MAHA/casereports/Case%20report%2052%20An%20unusual%20cause%20for%20neonatal%20abstinence%20syndrome.pdf" target="_blank">Open PDF</a>
      </li>

    </ul>
  </div>
</section>
  <footer class="footer">
  <div class="container">
    <p>Â© 2026 Kratom Regulatory Review</p>
  </div>
</footer>

</body>
</html>
  
